worker_spiーエッセンス(3)ー(2/3)
sap_spi.book
298
目次 商標について.1 表記内容について.1 1 エディタ.2 1.1bluefish.2 1.2texi2html.2 2 科学.3 2.1chemtool.3 2.2Rasmol.3 2.3celestia.3 3 画像.4 3.1Blender.4 3.2tgif.4 4 数学.5 4.1ge
15
数量 (ton) 4, 35, 3, 25, 2, 15, 1, 2, 2,4 5,8 19, 55 2, 2,4 5,9 19,8 3,5 3, 4, 19,8 3,1 3, 3,9 19, 3,15 2,9 3,7 18,4 3,2 2,8 3,8 18,7 3,25 2,8 3,9 19, 3
6
3 2 2 (1) (2) (3) (4) 4 4 AdaBoost 2. [11] Onishi&Yoda [8] Iwashita&Stoica [5] 4 [3] 3. 3 (1) (2) (3)
6
2 3 Fig. 2 3-layer structure model ( 3 ) Fig. 1 1 Period for increasing knowledge and familiarity ) 3 ( 2 ) ( 2(a)) 2 6 (
8
IEEJ: m m3 2.1 m3 0.4 m3 8.4 m3 1.2 m3 2.9 m3 7.4 m3 4.2 m3 0.3 m3 2.5 m3 1.6 m3 2.2 m3 6.6 m ,727 m3 9,477 m3 2 7,204 m3
48
the symbol grounding problem *2 *3 2 *4 robot ethics (1) (2) (3) (1) (2) (3) (3) (2) (3) *2 Cf Taddeo and Floridi [16] *3 Cf. Clark [4, 5]
11
(1) (2) (3) (4) (1) (2) (3) (4) (5) (1) (2) (3) (4) (5) (1) (2) (3) (4) S&L (1) (2) (3) S&L (4) (5) (1) (2) (3) (4) (1) (2) 2 New York
64
Fig. 1 Structure of pyridalyl R 3,3-Dichloro-2-propenyloxy compound 1 H CF3 (CH2) 3,3-Dichloro-2-propenyloxy compound 2 Lead compound 3 (Insecticidal
12
,. Elastgraphy.,.,,.. Elastgraphy,. SY Kupffer 1 2 3, 2, 2, 2, 2, 3, 3, 3, 4, 2 3 1, 2, 3, 4,.,,B mode.fibroscan 502 Controlled Attenuation Parameter
44
ビタミン B 12 人工酵素 2 C 2 C 3 C 3 C 2 C 3 C C 3 C 2 C 3 C 2 L Co C 3 C 3 C 3 C 3 L C2 2 B 12 LC 3 B 12 LC B 12 C C X 2 C 3 X C 3 P C 2 5,6-2 CoA C CoA C -C
6
₂₈ TFT 1 ₁ ₁ 1, 1, 1, 1, 2, 3, 3, 3 1, 2, 3 B-Flow,., B-Flow B Flow. 2, , 2, 3.,,. Logiq S8 GE. ₁ ₂ 1, 1, 1, 1, 2, 3, 3, 3
18
CPU LSI [10] 3 3D [2] TSV [2], [12] TSV 3 [1], [12] Loh 3 [7]Puttaswamy [9] Cong [12] 3 [6] 2.3 [2] ( )
5
2. Surface parameterization,,,,,, 2 φ,φ 2 M M 2, M,M 2, ) S 2 Surface parameterization 3 S [4], [5].. ) 0,, 3, [4] φ : R 3 R 2, φ = 0 F φ) = φ 2. 3) 3
5
* *1 *2 *2 *4 *5 *3 *3 *3 *6 *7
72
i 1 () ii 2 iii 2.1 () iii 2.2 () iv 3 v 3.1 / () v 3.2 / ()
47
2-1-2 ( ) 4) (1)2-1-3(2) (1) 2-1-3(2)
83
Feb THE JAPANESE JOURNAL OF ANTIBIOTICS ,4 2,4 2,4 2,3,4 2,3,4 2,3, ,3, Garenoxacin GRNX Levofloxacin LV
14
(1) (2) (3) (4) (1) 54 (2) (1) (2) (1) (2) (3)
341
3 3 3 Knecht (2-3fps) AR [3] 2. 2 Debevec High Dynamic Range( HDR) [4] HDR Derek [5] 2. 3 [6] 3. [6] x E(x) E(x) = 2π π 2 V (x, θ i, ϕ i )L(θ
7